David Epstein
Founder at BLACK DIAMOND THERAPEUTICS, INC.
Net worth: 5 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Douglas A. Hamilton | M | 57 | 10 years | |
| Mark Velleca | M | 60 | 3 years | |
| Elizabeth Buck | M | 49 | 11 years | |
| Frederick Pierce | M | 63 | 9 years | |
| Brent Hatzis-Schoch | M | 59 | 5 years | |
| Ali Behbahani | M | 47 | 6 years | |
| Garry Menzel | M | 59 | 10 years | |
| Kapil Dhingra | M | 64 | 3 years | |
| Samarth Kulkarni | M | 45 | 5 years | |
| Fang Ni | M | 37 | 4 years | |
| Erika Jones | F | 39 | 5 years | |
| Sergey Yurasov | M | 55 | 2 years | |
| Elizabeth Montgomery | F | 52 | 2 years | |
| Julie Seidel | F | - | - | |
| Melanie Morrison | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert van Nostrand | M | 67 | 21 years | |
| Michael Atieh | M | 70 | 5 years | |
| Robert Alexander Ingram | M | 81 | 10 years | |
| Richard Berman | M | 81 | 3 years | |
| Karsten Witt | M | 68 | 13 years | |
| Colin Goddard | M | 64 | 21 years | |
| Dominic Piscitelli | M | 50 | 10 years | |
| Alexander Mayweg | M | 49 | 7 years | |
| Thomas Leggett | M | 47 | 2 years | |
| H. Philip Goodeve | M | 63 | 3 years | |
| Raj Shah | M | 46 | 6 years | |
| Pierre Legault | M | 63 | 1 years | |
| Chuck Wilson | M | 59 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 7 years |
| Martin Driscoll | M | 65 | 2 years | |
| Barbara Wood | F | 62 | 9 years | |
| David Siegel | M | 61 | 3 years | |
| Bradley Bolzon | M | 64 | - | |
| Wendy Dixon | M | 68 | 2 years | |
| Patrick T. Mooney | M | 55 | 2 years | |
| Joseph Klein | M | 62 | 4 years | |
| John P. White | M | - | 25 years | |
| Pritesh Shah | M | 46 | - | |
| Joseph Talamo | M | 55 | 14 years | |
| Jonathan Pachter | M | 66 | 6 years | |
| Neil Gibson | M | 67 | 6 years | |
| Peter Melnyk | M | 62 | 8 years | |
| Rachel Humphrey | M | 62 | 1 years | |
| Lee Arnold | M | 64 | 4 years | |
| Andy Crew | M | 59 | 11 years | |
| Linda Friedman | F | - | - | |
| Thilo Schroeder | M | 42 | - | |
| Robert Wild | M | 53 | 4 years | |
| Walter M. Lovenberg | M | 89 | 15 years | |
| Shauna M. Tholen | F | - | 3 years | |
| Pablo Cagnoni | M | 60 | 3 years | |
| G. Morgan Browne | M | 89 | 14 years | |
| Amy Sheehan | F | - | 13 years | |
| Natalie Wildenradt | F | - | - | |
| Naoki Okamura | M | 61 | 1 years | |
| Jason Kim | M | 49 | 2 years | |
| William E. Fitzsimmons | M | - | - | |
| Paul Chaney | M | 66 | 2 years | |
| Mark P. Richmond | M | 92 | 7 years | |
| Viren Mehta | M | 74 | 11 years | |
| David W. Ghesquiere | M | 57 | 5 years | |
| Daryl K. Granner | M | 87 | 13 years | |
| Anker Gunvald Lundemose | M | 63 | 5 years | |
| Kenneth Lee | M | 76 | 3 years | |
| Herbert Michael Pinedo | M | 78 | 6 years | |
| Patrick M. Shea | M | - | - | |
| Santo Costa | M | 78 | 4 years | |
| Peter Barrett | M | 71 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 8 years |
| David Niemiec | M | 74 | 9 years | |
| Andrew Ellington | M | - |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | - |
| Katharine Stevenson | F | 61 | 5 years | |
| Stephen Knowles | M | - | - | |
| Michael Ross | M | 75 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | - |
| Ronald R. Breaker | M | - |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | - |
| Kin Yip Leung | M | 62 | 7 years | |
| Christopher D. Roberts | M | 54 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 75 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Epstein
- Personal Network
